Memphasys Limited (ASX:MEM)
Australia · Delayed Price · Currency is AUD 0.0060
+0.0005 (9.09%)
Apr 23, 2026, 10:44 AM AEST
Memphasys Market Cap
Memphasys has a market cap or net worth of 17.08 million as of April 24, 2026. Its market cap has increased by 37.82% in one year.
Market Cap
17.08M
Enterprise Value
21.04M
Revenue
213.98K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since May 14, 2007, Memphasys's market cap has increased from 5.33M to 17.08M, an increase of 220.60%. That is a compound annual growth rate of 6.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 17.08M | -9.18% |
| Dec 31, 2025 | 18.81M | 32.77% |
| Dec 31, 2024 | 14.17M | 4.43% |
| Dec 29, 2023 | 13.57M | 1.01% |
| Dec 30, 2022 | 13.43M | -81.77% |
| Dec 31, 2021 | 73.67M | -2.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HeraMED | 56.59M |
| Micro-X | 39.97M |
| Nova Eye Medical | 39.88M |
| CleanSpace Holdings | 35.51M |
| ImpediMed | 30.58M |
| CurveBeam AI | 29.62M |
| Atomo Diagnostics | 25.23M |
| Control Bionics | 24.72M |